PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 151 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,883,000 | +304.1% | 836,789 | +265.9% | 0.00% | +300.0% |
| Q4 2018 | $961,000 | -51.4% | 228,711 | -21.5% | 0.00% | -66.7% |
| Q2 2017 | $1,979,000 | -13.9% | 291,489 | +19.8% | 0.00% | 0.0% |
| Q1 2017 | $2,298,000 | +44.3% | 243,389 | +15.5% | 0.00% | -25.0% |
| Q4 2014 | $1,593,000 | +13.3% | 210,698 | -24.8% | 0.00% | +33.3% |
| Q3 2013 | $1,406,000 | +205.7% | 280,100 | +171.7% | 0.00% | +200.0% |
| Q2 2013 | $460,000 | – | 103,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 6,158,000 | $38,611,000 | 2.32% |
| ARDSLEY ADVISORY PARTNERS LP | 2,045,000 | $12,822,000 | 1.73% |
| RA Capital Management | 3,030,303 | $19,000,000 | 1.02% |
| Phocas Financial Corp. | 1,736,386 | $10,887,000 | 0.95% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $3,135,000 | 0.42% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,345,260 | $8,435,000 | 0.30% |
| BKS ADVISORS, LLC | 115,115 | $721,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,530,657 | $9,597,000 | 0.20% |
| CARILLON TOWER ADVISERS, INC. | 3,948,024 | $24,745,000 | 0.18% |
| EAGLE ASSET MANAGEMENT INC | 4,444,673 | $27,868,000 | 0.14% |